Cargando…
Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
OBJECTIVE: Myeloproliferative neoplasms (MPNs) are hematopoietic stem cell (HSC)-originated diseases with clonal myeloproliferation. The constitutive activation of the JAK/STAT pathway is frequently detected in patients with Philadelphia chromosome-negative (Ph(–)) MPNs with an acquired JAK2V617F mu...
Autores principales: | Uslu Bıçak, İldeniz, Tokcan, Berkay, Yavuz, Akif Selim, Sözer Tokdemir, Selçuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979741/ https://www.ncbi.nlm.nih.gov/pubmed/36458557 http://dx.doi.org/10.4274/tjh.galenos.2022.2022.0343 |
Ejemplares similares
-
Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2017) -
Gene expression profiling of CD34(+) cells from patients with myeloproliferative neoplasms
por: Sharma, Mugdha, et al.
Publicado: (2021) -
Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34(+) cells
por: Pozzi, Giulia, et al.
Publicado: (2022) -
Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009) -
Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)